Ross Lamb had no idea that Angelina Jolie’s double mastectomy could have anything to do with his prostate cancer. Until he ...

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...

Diseases like cancer or neurodegeneration are known to arise from genetic misfires. But treating such complex conditions hasn ...

An international group have discovered associations between pathogenic variants of the BRCA 1 and 2 genes and four types of ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

Researchers have found a link between healthier diets containing fruits, vegetables, and whole grains and higher rates of ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System, one of the leading academic health systems in the United States, ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

In this episode of Community Corner, Christopher H. Lieu, MD, professor of medicine at the University of Colorado Cancer ...

An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...